Grip, L.

patient trial tranilast study restenosi group angioplasty abciximab placebo infarction treatment patency angiographic result artery tissue plasminogen activator grade follow-up vessel laboratory glycoprotein emergency room therapy university 45 min placebo group frequency antagonist angiographic restenosis effect circulation hospital angiography investigator month emergency lesion abciximab bolus figure heparin infarct-related artery target table receptor randomized point treatment groups efficacy 3 months thrombolytic thrombolysi thrombolytic therapy reperfusion efficacy end point stenosi pilot netherland comparison difference infarct-related symptom catheterization laboratory stent /iiia activator value aspirin reduction plasminogen platelet ami jacc vol van den merkhof population grape analysis interval revascularization onset tissue heart